IFM Investors has announced two separate acquisitions, involving the purchase of the remaining 50% stake in Nala Renewables ...

Atlas Arteria’s board unanimously recommends shareholders reject IFM’s hostile bid, calling it too low and highly conditional. The post Atlas Arteria directors urge investors to reject IFM's takeover ...

The investment giant has long been unhappy with the ASX-listed tollroad operator’s strategy, despite being its largest backer ...

Industry super’s IFM Investors has strangled tollroads investor Atlas Arteria with its kitbag of raids, creeps and boardroom games, so it may as well finish the job. The only problem is its intent on ...

IFM Investors launched the hostile takeover, claiming the toll road operator's continued search for mergers and acquisitions will impact shareholder value.

IFM Investors, the largest shareholder in Atlas Arteria with a 35.68% stake, has launched a hostile A$6.9bn (€4.2bn) bid to acquire the remaining shares of the Australia-listed toll road operator, ...

Novartis is stepping on the cGAS. Three years after securing an option on an IFM Therapeutics subsidiary, the Swiss drugmaker has accelerated into the deal and paid $90 million upfront for small ...

The deal is expected to close in the first quarter of this year Marathon Capital acted as financial advisor to GreenGas on the transaction IFM Investors has $143 billion under management as of ...

Australian investment manager IFM Investors will wind down its domestic private equity unit in coming years, citing a lack of scale to make it commercially viable and a focus on other global ...